4/10
10:23 am
evmn
Evommune (EVMN) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $48.00 price target on the stock.
Medium
Report
Evommune (EVMN) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $48.00 price target on the stock.
4/10
10:23 am
evmn
Evommune (EVMN) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $48.00 price target on the stock.
Medium
Report
Evommune (EVMN) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $48.00 price target on the stock.
4/10
10:01 am
evmn
Rating for EVMN
Medium
Report
Rating for EVMN
4/10
10:01 am
evmn
Rating for EVMN
Medium
Report
Rating for EVMN
4/7
10:11 am
evmn
Evommune (EVMN) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $50.00 price target on the stock.
Report
Evommune (EVMN) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $50.00 price target on the stock.
3/17
06:52 am
evmn
Evommune (EVMN) was upgraded by Royal Bank Of Canada to "moderate buy".
Medium
Report
Evommune (EVMN) was upgraded by Royal Bank Of Canada to "moderate buy".
3/17
06:52 am
evmn
Evommune (EVMN) was upgraded by Royal Bank Of Canada to "moderate buy".
Medium
Report
Evommune (EVMN) was upgraded by Royal Bank Of Canada to "moderate buy".
3/10
06:06 am
evmn
Evommune initiated with an Outperform at RBC Capital
Medium
Report
Evommune initiated with an Outperform at RBC Capital
3/10
06:06 am
evmn
Evommune initiated with an Outperform at RBC Capital
Medium
Report
Evommune initiated with an Outperform at RBC Capital
2/18
02:14 pm
evmn
Evommune (NYSE:EVMN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Evommune (NYSE:EVMN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/18
02:14 pm
evmn
Evommune (NYSE:EVMN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Evommune (NYSE:EVMN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/10
02:13 pm
evmn
Evommune (NYSE:EVMN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Evommune (NYSE:EVMN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
2/10
02:13 pm
evmn
Evommune (NYSE:EVMN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Evommune (NYSE:EVMN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/22
09:17 am
evmn
Rating for EVMN
Low
Report
Rating for EVMN
1/22
09:17 am
evmn
Rating for EVMN
Low
Report
Rating for EVMN
1/22
09:00 am
evmn
Evommune (NYSE:EVMN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $42.00 price target on the stock.
Medium
Report
Evommune (NYSE:EVMN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $42.00 price target on the stock.
1/22
08:12 am
evmn
Evommune initiated with an Outperform at Oppenheimer
Low
Report
Evommune initiated with an Outperform at Oppenheimer
1/22
08:12 am
evmn
Evommune initiated with an Outperform at Oppenheimer
Low
Report
Evommune initiated with an Outperform at Oppenheimer